AMERISAFE, Inc. (NASDAQ:AMSF – Get Free Report) shares gapped down before the market opened on Wednesday following a weaker than expected earnings announcement. The stock had previously closed at $33.98, but opened at $32.29. AMERISAFE shares last traded at $32.6280, with a volume of 16,746 shares changing hands.
The insurance provider reported $0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.52 by ($0.08). AMERISAFE had a net margin of 14.00% and a return on equity of 14.87%. The company had revenue of $91.97 million for the quarter, compared to the consensus estimate of $85.09 million.
AMERISAFE Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Friday, September 11th will be given a dividend of $0.41 per share. The ex-dividend date is Friday, September 11th. This represents a $1.64 annualized dividend and a dividend yield of 5.4%. AMERISAFE’s dividend payout ratio (DPR) is 67.49%.
More AMERISAFE News
- Positive Sentiment: AMERISAFE said Q2 premium growth remained strong, and revenues came in above expectations, suggesting ongoing demand in its workers’ compensation insurance business. AMERISAFE Inc (AMSF) Q2 2026 Earnings Call Highlights: Strong Premium Growth Amid Market Challenges
- Positive Sentiment: The company declared a quarterly dividend of $0.41 per share, which supports the stock’s income appeal. AMERISAFE declares $0.41 dividend
- Neutral Sentiment: Management’s earnings-call tone was cautious, emphasizing growth but also headwinds in the broader market and operating environment. AMERISAFE Earnings Call Highlights Growth Amid Headwinds
- Negative Sentiment: Q2 earnings missed analyst estimates, with higher expenses, weaker underwriting margins, and lower investment income weighing on results. AMERISAFE Q2 Earnings Miss Estimates Despite Strong Premium Growth
- Negative Sentiment: Shares have continued to weaken as investors digest the earnings miss and broader concerns about the stock’s valuation versus its recent trading level. A Look at AMERISAFE Inc (AMSF) After 8.3% Decline — GF Value $39.74 vs Price $31.15
Wall Street Analyst Weigh In
AMSF has been the subject of several research reports. Truist Financial cut their target price on shares of AMERISAFE from $34.00 to $32.00 and set a “hold” rating for the company in a research report on Thursday. Wall Street Zen upgraded AMERISAFE from a “strong sell” rating to a “sell” rating in a research report on Saturday, May 23rd. Citizens Jmp dropped their price target on AMERISAFE from $50.00 to $45.00 and set a “market outperform” rating for the company in a research note on Monday, April 13th. Finally, Weiss Ratings upgraded AMERISAFE from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, July 14th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $44.00.
Check Out Our Latest Report on AMERISAFE
Hedge Funds Weigh In On AMERISAFE
A number of large investors have recently bought and sold shares of AMSF. AQR Capital Management LLC grew its holdings in shares of AMERISAFE by 5.1% in the first quarter. AQR Capital Management LLC now owns 83,478 shares of the insurance provider’s stock worth $4,387,000 after purchasing an additional 4,050 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in AMERISAFE by 4.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,313 shares of the insurance provider’s stock valued at $594,000 after buying an additional 471 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in AMERISAFE by 82.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 217,280 shares of the insurance provider’s stock valued at $11,418,000 after buying an additional 98,293 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in AMERISAFE by 8.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 43,118 shares of the insurance provider’s stock valued at $2,266,000 after buying an additional 3,435 shares during the period. Finally, Jane Street Group LLC boosted its position in AMERISAFE by 106.8% during the 1st quarter. Jane Street Group LLC now owns 29,176 shares of the insurance provider’s stock valued at $1,533,000 after buying an additional 15,070 shares during the period. 97.41% of the stock is owned by hedge funds and other institutional investors.
AMERISAFE Trading Down 2.9%
The business’s fifty day simple moving average is $32.33 and its 200-day simple moving average is $33.89. The firm has a market cap of $565.49 million, a P/E ratio of 12.19 and a beta of 0.23.
AMERISAFE Company Profile
Amerisafe, Inc (NASDAQ: AMSF) is a specialty provider of workers’ compensation insurance products and services in the United States. The company focuses on underwriting and managing workers’ compensation policies for small to mid-sized public and private businesses, particularly in higher-hazard industries such as retail, manufacturing, distribution and wholesale. Through its network of independent agents, Amerisafe delivers tailored coverage solutions that combine robust risk management support with loss prevention programs designed to enhance workplace safety.
In addition to core insurance offerings, Amerisafe provides extensive risk control resources, including safety training, on-site consultations and claims management services.
Further Reading
- Five stocks we like better than AMERISAFE
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter.
